Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
15.25
-0.78 (-4.87%)
At close: Aug 12, 2026, 4:00 PM EDT
10.92
-4.33 (-28.39%)
Pre-market: Aug 13, 2026, 7:40 AM EDT
Cellebrite DI Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 141.25 | 124.46 | 191.66 | 189.52 | 87.65 | 145.97 |
Short-Term Investments | 301.28 | 312.59 | 255.56 | 113.41 | 95.98 | 35.59 |
Cash & Short-Term Investments | 442.53 | 437.05 | 447.22 | 302.92 | 183.62 | 181.57 |
Cash Growth | -6.28% | -2.27% | 47.64% | 64.97% | 1.13% | -23.60% |
Accounts Receivable | 110.78 | 104.97 | 82.36 | 77.27 | 78.76 | 67.51 |
Inventory | 8.39 | 7.6 | 8.94 | 9.94 | 10.18 | 6.51 |
Other Current Assets | 27.98 | 26.23 | 29.07 | 31.95 | 23.37 | 17.63 |
Total Current Assets | 589.68 | 575.85 | 567.59 | 422.08 | 295.93 | 273.21 |
Net Property, Plant & Equipment | 40.97 | 38.52 | 27.6 | 30.16 | 32.91 | 16.76 |
Other Intangible Assets | 121.91 | 81.47 | 11.31 | 10.59 | 11.25 | 11.23 |
Goodwill | 119.56 | 119.56 | 28.71 | 26.83 | 26.83 | 26.83 |
Long-Term Investments | 103.19 | 97.96 | 36.6 | 28.86 | 22.13 | - |
Other Long-Term Assets | 19.01 | 25.5 | 18.75 | 14.37 | 14.24 | 11.76 |
Total Assets | 994.31 | 938.85 | 690.57 | 532.89 | 403.29 | 339.78 |
Accounts Payable | 18.11 | 16.83 | 11.08 | 8.28 | 4.61 | 9.55 |
Accrued Expenses | 77.01 | 71.24 | 63.33 | 44.85 | 45.45 | 54.04 |
Current Portion of Leases | 5.74 | 4 | 4.13 | 4.97 | 5 | - |
Unearned Revenue | 263.35 | 277.58 | 216.97 | 195.73 | 152.71 | 122.98 |
Total Current Liabilities | 364.21 | 369.66 | 295.5 | 253.82 | 207.78 | 186.57 |
Long-Term Leases | 17.49 | 18.67 | 6.84 | 9.16 | 10.35 | - |
Other Long-Term Liabilities | 74.51 | 66.2 | 52.2 | 235.69 | 111.3 | 226.56 |
Total Long-Term Liabilities | 92.01 | 84.88 | 59.05 | 244.85 | 121.65 | 226.56 |
Total Liabilities | 456.21 | 454.53 | 354.55 | 498.67 | 329.43 | 413.13 |
Treasury Stock | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 |
Additional Paid-in Capital | 605.81 | 568.72 | 498.88 | -84.9 | -125.62 | -153.07 |
Accumulated Other Comprehensive Income | 1.6 | 2.22 | 2.09 | 1.05 | 0.33 | 1.37 |
Retained Earnings | -69.23 | -86.54 | -164.86 | 118.14 | 199.24 | 78.44 |
Total Common Shareholders' Equity | 538.1 | 484.32 | 336.02 | 34.21 | 73.87 | -73.35 |
Shareholders' Equity | 538.1 | 484.32 | 336.02 | 34.21 | 73.87 | -73.35 |
Total Liabilities & Equity | 994.31 | 938.85 | 690.57 | 532.89 | 403.29 | 339.78 |
Total Debt | 23.23 | 22.67 | 10.97 | 14.13 | 15.36 | 0 |
Net Cash (Debt) | 419.3 | 414.38 | 436.25 | 288.79 | 168.27 | 181.57 |
Net Cash Growth | -6.79% | -5.01% | 51.06% | 71.63% | -7.32% | -23.60% |
Net Cash Per Share | 1.67 | 1.66 | 2.08 | 1.52 | 0.86 | 1.12 |
Book Value | 538.1 | 484.32 | 336.02 | 34.21 | 73.87 | -73.35 |
Book Value Per Share | 2.14 | 1.94 | 1.60 | 0.18 | 0.38 | -0.45 |
Tangible Book Value | 296.63 | 283.29 | 296 | -3.21 | 35.78 | -111.4 |
Tangible Book Value Per Share | 1.18 | 1.13 | 1.41 | -0.02 | 0.18 | -0.69 |